- Generate evidence for clinical, economic, and humanistic outcomes
- PRO endpoint validation, tool selection/development
- Identification of novel endpoints for clinical trials
- Custom epidemiology models to assess the incidence and prevalence of diseases
- Epidem-based inline and market forecast models
- Disease progression
- Cost-effectiveness analyses
- Cost-benefit analyses
- Budget impact analyses
- Return on investment models
Value Evidence Communication
- Value dossiers
- Slide presentations and other Market Access collaterals
RWE & Big Data Realization
- Common data models (OMOP or custom)
- Custom workflows / Analytics
- Efficacy-effectiveness gap
- Value-based contracting support
SLR & Meta-analysis
- Curated custom data sets for outcomes analysis
- Datasets for indirect treatment comparisons
- Regulatory submissions
Excelra Makes Strategic Investment in Anlitiks
A Disruptive HEOR and RWE Technology-led Consulting Company
The investment reinforces Excelra’s push into the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) analytics area. This deal is a testimony to Excelra’s commitment to drug discovery and commercialization by combining deep scientific domain expertize with cutting-edge technology and analytics solutions.
Ready to get more from data?
Tell us your objectives.
We will help you get there.
Embark on a new era of research management with our ELN/LIMS services. Experience seamless data organization, accelerated workflows, and enhanced collaboration. Connect with us today to elevate your research efficiency through our advanced ELN/LIMS solutions.
"*" indicates required fields